Literature DB >> 26030850

β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation.

Bryce A Mander1, Shawn M Marks2, Jacob W Vogel2, Vikram Rao1, Brandon Lu3, Jared M Saletin1, Sonia Ancoli-Israel4, William J Jagust5, Matthew P Walker6.   

Abstract

Independent evidence associates β-amyloid pathology with both non-rapid eye movement (NREM) sleep disruption and memory impairment in older adults. However, whether the influence of β-amyloid pathology on hippocampus-dependent memory is, in part, driven by impairments of NREM slow wave activity (SWA) and associated overnight memory consolidation is unknown. Here we show that β-amyloid burden in medial prefrontal cortex (mPFC) correlates significantly with the severity of impairment in NREM SWA generation. Moreover, reduced NREM SWA generation was further associated with impaired overnight memory consolidation and impoverished hippocampal-neocortical memory transformation. Furthermore, structural equation models revealed that the association between mPFC β-amyloid pathology and impaired hippocampus-dependent memory consolidation was not direct, but instead statistically depended on the intermediary factor of diminished NREM SWA. By linking β-amyloid pathology with impaired NREM SWA, these data implicate sleep disruption as a mechanistic pathway through which β-amyloid pathology may contribute to hippocampus-dependent cognitive decline in the elderly.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26030850      PMCID: PMC4482795          DOI: 10.1038/nn.4035

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


Introduction

Cognitive decline is a problematic and disabling consequence of aging, with impairments in hippocampus-dependent memory being one of the most debilitating symptoms[1-4]. The accumulation of cortical β-amyloid (Aβ) and subcortical tau proteins within the brain are leading candidate mechanisms underlying hippocampus-dependent memory impairment in aging and Alzheimer’s disease (AD)[2-5]. While tau pathology predominantly accumulates initially within medial temporal lobe structures, including the hippocampus[3, 5], β-amyloid pathology predominates in cortex, with the earliest deposition including cortical regions such as the medial prefrontal cortex (mPFC)[2, 4]. Evidence implicates both pathologies in memory failure in even healthy older adults[3, 5, 6]. Though tau pathology appears to exert its influence on memory through direct degeneration of hippocampal synapses[5], the mechanisms through which Aβ compromises hippocampus-dependent memory remain unclear. Aβ pathology does not aggregate substantively within the hippocampus[2, 3], but has been associated with memory through its effects on hippocampal-neocortical network structure, function, and connectivity[6, 7], and through its association with hippocampal tau pathology[5]. However, since the direct influence of Aβ and tau neuropathology explains only a moderate proportion of the variance in age-related cognitive decline[1], it remains possible that Aβ pathology also impacts hippocampus-dependent memory indirectly, through other pathways that impact memory-relevant hippocampal-neocortical functioning. One novelpathway through which cortical Aβ may trigger hippocampus-dependent memory deficits is through its disruption of non-rapid eye movement (NREM) sleep and associated slow wave activity (SWA)[8-11]. Several independent lines of evidence support this hypothesis. First, older adults exhibit marked reductions in NREM SWA, with these reductions being associated with the degree of memory impairment observed[8-13]. Second, the degree of disrupted prefrontal NREM SWA in older adults is associated not only with the degree of impaired overnight memory retention[11], but is further associated with persistent retrieval-related hippocampal activation that reflects impoverished hippocampal-neocortical memory transformation[11]. Third, experimentally increasing NREM SWA, particularly in the slow <1Hz frequency range, causally enhances subsequent consolidation and thus long-term memory retention in young adults[14]. Fourth, there is strong homology between source generators of NREM slow wave oscillations, which predominate in medial prefrontal cortex (mPFC)[15], and the cortical regions where Aβ preferentially aggregates in both cognitively normal older adults and Alzheimer’s disease patients[2, 15]. Fifth, age-related NREM slow wave sleep disruption is exacerbated early in the course of Alzheimer’s disease and mild cognitive impairment; groups known to have elevated Aβ burden[13, 16, 17], with these NREM sleep disruptions predicting the severity of observed memory impairment[13, 18]. Finally, recent studies in humans and rodents demonstrate that interstitial Aβ levels rise and fall with the brain states of wake and NREM sleep, respectively. Indeed, shorter NREM sleep duration and greater NREM sleep fragmentation has been reported in mice over-expressing Aβ proteins[19, 20], while human subjective reports of reduced sleep duration and diminished sleep quality correlate with cortical Aβ burden in healthy older adults[21]. Moreover, direct manipulations of sleep and Aβ production in rodent models of AD have established bidirectional relationships between both factors[19, 20, 22]. Together, these data generate the untested hypothesis that the severity of local Aβ accumulation within mPFC is significantly associated with diminished NREM slow wave activity that, in turn, further correlates with the extent of impaired overnight hippocampus-dependent memory consolidation in older adults. Here, we test this hypothesis by combining [11C]PIB PET scanning, offering in vivo estimates of regional Aβ burden, together with an experimental night of sleep electroencephalography (EEG) recording, and a behavioral and functional magnetic resonance imaging (fMRI) test of sleep-dependent memory consolidation. Utilizing these methods, we hypothesized that the accumulation of Aβ within the mPFC would be associated with disrupted memory retention through its association with NREM slow wave activity. Specifically, we predicted that mPFC Aβ burden would significantly correlate with severity of disrupted NREM slow wave activity, particularly in the 0.6–1Hz range known to promote memory consolidation[14, 23]. Second, we hypothesized that such disruption in NREM SWA would correlate with the degree of impaired overnight memory retention and persistent reliance (rather than progressive independence) of post-sleep retrieval on hippocampal activity. Third, bridging these relationships, we posited that the association between mPFC β-amyloid pathology and impaired hippocampus-dependent memory was not direct (i.e., independent of sleep), but instead, significantly accounted for by the intermediary factor of diminished NREM SWA.

Results

In short (see Methods), twenty-six cognitively normal older adults (Table 1) received a PIB-PET scan, and performed a sleep-dependent episodic associative (word-pair) task before and after a night of polysomnographically (PSG) recorded sleep, with next-day retrieval-related brain activity measured using functional MRI (fMRI). For the memory test, all participants were initially trained to criterion on a set of word pairs in the evening, pre-sleep, followed by two separate recognition memory tests. The first (“short delay”) recognition memory test occurred 10 minutes after the initial study session, where a subset of the studied word pairs were tested.
Table 1

Demographic and Neuropsychological Measures (mean±s.d.)

VariableSubjects (n = 26)
Age (yr)75.1±3.5
Gender18 Female
Education (yr)16.5±2.2
MMSE29.5±1.0
PIB Index1.13±0.21
mPFC PIB1.16±0.25
Occipital Lobe PIB1.10±0.08
Temporal Lobe PIB1.07±0.18
Parietal Lobe PIB1.15±0.19
DLPFC PIB1.15±0.26
Mean bed time22:55±1:20
Mean wake time7:20±1:15
Mean prestudy time in bed (hr)8.42±0.73
Mean prestudy sleep time (hr)7.24±0.91
Mean prestudy sleep latency (min)38.5±45.3
Mean prestudy sleep efficiency (%)86.2±10.1
Short delay recognition (HR–FAR–LR)0.14±0.25
Long delay recognition (HR–FAR–LR)−0.49±0.32
Memory Change (long–short delay)−0.64±0.29
Neuropsychological Measures
CVLT (long delay, # free recalled)10.6±3.0
WMS (visual reproduction %)71.3±15.9
Trailmaking B (seconds)76.0±35.7
Stroop (# correct in 60 seconds)47.6±13.6
Following the short delay recognition test, participants were given the in laboratory 8 hour sleep recording period in accordance with habitual sleep-wake habits. The next morning, participants performed the second (“long delay”) post-sleep recognition test during an fMRI scanning session, where the remaining subset of originally studied word pairs were tested. Functional MRI scanning was employed to assess post-sleep retrieval-related activity, focused a priori on the hippocampus[24]. The measure of overnight memory retention was calculated by subtracting short delay recognition performance from long delay recognition performance[8, 11].

β-amyloid and NREM SWA

Given our hypothesized associations between Aβ pathology, NREM slow wave sleep and episodic memory retention, we first examined associations between mPFC NREM SWA (mean at FZ and CZ derivations) and Aβ pathology (the latter indexed using PIB-PET distribution volume ratios; DVRs) (Fig. 1a–d). Because of the causal role of lower frequency (<1Hz) NREM SWA in memory consolidation[14, 23], we first examined the impact of Aβ on NREM SWA by frequency. A two-way, repeated measures ANCOVA, with frequency [0.6–1Hz/1–4Hz] as a within subjects factor and mPFC PIB as a between subjects covariate, revealed a significant frequency×mPFC PIB interaction (P=0.032; Fig. 2a). Specifically, greater mPFC PIB DVR was associated with lower NREM SWA in the 0.6–1Hz range (parameter estimate t=−2.29, P=0.031), but not within the faster frequency range NREM SWA (1–4Hz: parameter estimate t=1.85, P=0.076) over prefrontal cortex. The proportion of mPFC SWA 0.6–1Hz was also negatively associated with mPFC PIB (r=−0.45, P=0.020; Fig. 2b). Moreover, the relationship between mPFC PIB and proportion of mPFC NREM SWA 0.6–1Hz persisted when accounting for the non-normal distribution of PIB DVRs by utilizing nonparametric analysis (Kendall’s τ=−0.30, P=0.035). Indicating specificity, no other significant NREM sleep associations were detected (Supplementary Table 1).
Figure 1

Aβ, NREM SWA, and memory retention measures in three sample subjects

[11C]PIB-PET DVR images demonstrating Aβ deposition (a), NREM SWA and associated localized slow wave source (b), proportion of NREM SWA 0.6–1Hz at FZ&CZ derivations (c), and overnight memory retention (long delay recognition testing – short delay recognition testing; d) measures in three sample participants with low mPFC PIB DVR (left column), intermediate mPFC PIB DVR (middle column), and high mPFC PIB DVR (right column). PIB-PET mPFC region of interest (ROI) is outlined in white (a) and the mPFC EEG derivations are outlined in black (b), with accompanying source analysis (thresholded at ±7) verifying mPFC overlap across PIB-PET and EEG ROIs (see Methods and Supplementary Fig. 2). Prop. denotes proportion, PIB denotes Pittsburgh compound B, PET denotes positron emission tomography, DVR denotes distribution volume ratio referenced against the whole cerebellum, mPFC denotes medial prefrontal cortex, and [HR–FAR–LR] denotes [hit rate to originally studied word pairs – false alarm rate to new, unstudied words – false alarm rate to originally studied word pairs].

Figure 2

Associations between Aβ, NREM SWA, and memory retention measures

Associations between LN transformed [11C]PIB-PET DVR measured mPFC Aβ deposition, mPFC relative SWA, mPFC SW density, and overnight memory retention. Interaction plots of two-way, repeated measures ANCOVAs, which revealed that Aβ burden was associated with lower relative mPFC NREM SWA and SW density 0.6–1Hz and higher mPFC NREM SWA and SW density at 1–4Hz (parameter estimates for each frequency bin plotted in a) for SWA and c) for SW density. mPFC Aβ burden was also negatively associated with proportion of mPFC NREM SWA 0.6–1Hz (b). mPFC NREM SWA 0.6–1Hz, in turn, positively predicted overnight memory retention (d). %PTOT denotes percentage of total spectral power (0.6–50Hz), Prop. denotes proportion, PIB denotes Pittsburgh compound B, PET denotes positron emission tomography, DVR denotes distribution volume ratio referenced against the cerebellum, mPFC denotes medial prefrontal cortex, and [HR–FAR–LR] denotes [hit rate to originally studied word pairs – false alarm rate to new, unstudied words – false alarm rate to originally studied word pairs].

These Aβ pathology associations remained significant when accounting for the factors of age, mPFC grey matter volume (optimized voxel based morphometry measure), and gender within the same statistical model (P=0.026 for mPFC PIB, yet P=0.753 for age, P=0.781 for grey matter, and P=0.660 for gender). While an exploration of gender was not part of the primary hypotheses, the latter non-significant effect should be appreciated cautiously, since the design and power of the study is not adequate to discount potential gender interactions. To address the mPFC specificity of our PIB DVR and NREM SWA 0.6–1Hz associations, two-way, repeated measures ANCOVA models were employed. In the first model we examine whether SWA at different derivations was associated with mPFC PIB DVRs. In this model, mPFC PIB was included as a between subjects covariate with location of proportion of NREM SWA 0.6–1Hz included as a within subjects factor [mPFC/dlPFC/Parietal/Temporal/Occipital]. In this model, Location (F=24.002, P<0.001) and Location×mPFC PIB DVR (F=2.568, P=0.043) were significant whereas mPFC PIB DVR was not (F=3.871, P=0.061). Parameter estimates from this model suggested that only frontal ‘locations’ were significantly associated with mPFC PIB DVR, with peak significance being detected over mPFC (for mPFC P=0.020; for dlPFC P=0.027; with non-significant associations for Parietal P=0.118, Temporal P=0.105 and Occipital P=0.162 locations). In the second ANCOVA model, the proportion of mPFC SWA 0.6–1Hz was included as a between subjects covariate with location of PIB DVR included as a within subjects factor [mPFC/dlPFC/Parietal/Temporal/Occipital]. In this model, Location (F=8.331, P<0.001) and Location×Proportion of mPFC SWA 0.6–1Hz (F=6.219, P<0.001) were significant, whereas the Proportion of mPFC SWA 0.6–1Hz was a trend (F=4.084, P=0.055). Thus, parameter estimates from this model suggested that only frontal regions were significantly associated with proportion of mPFC SWA 0.6–1Hz, with peak significance being detected over mPFC (for mPFC P=0.020; for dlPFC P=0.034; and trends or non-significant associations for Parietal P=0.072, Temporal P=0.162, and Occipital P=0.217). Finally, mPFC PIB was not associated with the proportion of REM delta power 0.6–1Hz over prefrontal cortex (r=−0.31, P=0.123; Kendall’s τ=−0.16, P=0.269), demonstrating that the association between mPFC PIB and SWA 0.6–1Hz was specific to NREM sleep. Further, no significant association between mPFC PIB and NREM spectral power was detected beyond the SWA range (Supplementary Fig. 3). Together, these data indicate that mPFC Aβ aggregation significantly predicts the degree of impoverished NREM SWA expressed over mPFC in the memory-relevant 0.6–1Hz range. To determine whether the association between β-amyloid pathology and NREM SWA 0.6–1Hz was driven by a reduction in the number of slow waves generated or a disruption in slow wave morphology, slow waves (SW) were detected and examined using an established algorithm[25]. Similar to mPFC NREM SWA, a two-way, repeated measures ANCOVA, with frequency [0.6–1Hz/1–4Hz] as a within subjects factor and mPFC PIB as a between subjects covariate, revealed a significant frequency×mPFC PIB interaction predicting mPFC slow wave density (P=0.020; Fig. 2c) but not mean slow wave period (P=0.257), amplitude (P=0.685) or slope (P=0.535). Congruent with the measure of mPFC NREM SWA, mPFC PIB was associated with lower mPFC SW density 0.6–1Hz (parameter estimate t=−2.623, P=0.015) and higher SW density at 1–4Hz (parameter estimate t=2.416, P=0.024). These data suggest that the association between NREM SWA 0.6–1Hz and β-amyloid pathology is statistically accounted for by the reduction in the incidence of 0.6–1Hz slow waves, rather than morphological changes in SW slope, amplitude, or period. That mPFC PIB was associated with reduced SW generation within the mPFC was explored by performing source analysis, using the validated sLORETA method[26], time-locking to the negative slow wave peak. Source analysis revealed that the peak current density associated with the negative peak of slow waves 0.6–1Hz detected at CZ and FZ was localized within the mPFC (Fig. 1b and Supplementary Fig. 1). These data support the conclusion that mPFC Aβ deposition is associated with fewer slow waves 0.6–1Hz generated within the mPFC.

NREM SWA and hippocampus-dependent memory

Next, we sought to determine whether reduced mPFC NREM SWA 0.6–1Hz, associated with higher mPFC β-amyloid burden, predicted impaired long-term memory retention in cognitively healthy older adults. The proportion of mPFC NREM SWA 0.6–1Hz (r=0.50, P=0.019; Fig. 2d) positively predicted memory retention, and remained a significant predictor when controlling for age and gender (P=0.022 for mPFC NREM SWA 0.6–1Hz, P=0.980 for age, P=0.494 for gender). Therefore, reductions in mPFC NREM SWA 0.6–1Hz predicted worse overnight memory retention. At the neural level, and consistent with a NREM sleep-dependent hippocampal-neocortical model of memory consolidation[27, 28], the severity of impairment in NREM SWA 0.6–1Hz was further associated with greater persistence (rather than progressive independence[11, 29–31]) of post-sleep retrieval-related hippocampal activation (r=−0.59, P=0.004; Fig. 3a). This association also remained significant when controlling for age and gender (P=0.006 for mPFC NREM SWA 0.6–1Hz, P=0.897 for age, P=0.657 for gender). Though this association was maximal in the left hippocampus, it was present bilaterally (Supplementary Fig. 2). No significant associations between retrieval-related HC activation and NREM spectral power were detected beyond the SWA range (Supplementary Fig. 3). Implicating diminished memory consolidation in this association between NREM SWA disruption and persistent hippocampal activity, post-sleep retrieval-related activation within the hippocampus significantly predicted worse overnight memory retention (r=−0.50, P=0.017) (Fig. 3b). Taken together, these data are consistent with the prediction that the severity of impairment in NREM SWA 0.6–1Hz detected over mPFC, in older adults, is significantly associated with worse overnight memory retention and persistent reliance on the hippocampus during next day retrieval.
Figure 3

Associations between NREM SWA, retrieval-related hippocampus activation, and memory retention

(a) Negative association between proportion of mPFC SWA 0.6–1Hz and left hippocampal activation greater during successful associative episodic retrieval than correct rejection of novel words (Hits-Correct Rejections); 8mm-sphere ROI: [x=−22, y=−14, z=−12; x=−23, y=−15, z=−16 in mni coordinates][24]. Activations were inclusively masked by hippocampal anatomy and displayed and considered significant at the voxel level of P<0.05 family-wise error (FWE) corrected for multiple comparisons within the a priori hippocampal region of interest. Peak effects were detected at [x=−24, y=−16, z=−14]. Hot colors represent the extent of the negative association between hippocampal activation and proportion of SWA 0.6–1Hz. (b) Negative association between overnight memory retention and the average contrast estimate of significant hippocampal voxels, extracted using marsbar[46]. au denotes arbitrary units, prop. denotes proportion, and [HR–FAR–LR] denotes [hit rate to originally studied word pairs – false alarm rate to new, unstudied words – false alarm rate to originally studied word pairs].

Aβ, SWA, and hippocampus-dependent memory consolidation

Having characterized the separate associations between mPFC Aβ pathology, NREM SWA deficits, and hippocampus-dependent memory impairment, we finally sought to determine the interactions between factors using path analysis[32]. Specifically, we tested the hypothesis that mPFC Aβ pathology exerted an influence on memory not directly, but instead, indirectly, through its association with impaired NREM SWA, thus compromising sleep-dependent consolidation of hippocampus-dependent memory. Three models were constructed (Fig. 4a–c) and compared to each other and standard saturation and independence control models to determine the nature of these interactions. The standardized metrics used to determine these interactions were: (1) root mean square residual (RMR), (2) goodness of fit index (GFI), and (3) Bayesian information criterion (BIC; see Methods)[33-35]. In short, RMR values near 0 and GFI values above 0.9 are considered evidence for sufficient model fit[34]. Lower BIC values suggest better model fits, with a difference in BIC of over 10 suggesting marked differences between the models, a difference of 6–10 suggesting a strong difference, and a difference of 2–6 suggesting marginal difference is present[35]. In the first model (Fig. 4a), mPFC Aβ pathology was allowed to directly predict deficits in memory retention independent of NREM SWA (proportion of mPFC NREM SWA 0.6–1Hz) and retrieval-related hippocampal activation. In the second model (Fig. 4b), mPFC Aβ pathology was associated with diminished memory retention independent of NREM SWA, instead, being directly associated through its impact on retrieval-related hippocampal activation. In the third, sleep-dependent, model (Fig. 4c), the associated influence of mPFC Aβ pathology on impaired memory retention was not direct. Instead, the influence of mPFC Aβ pathology was indirect, through its effects on diminished NREM SWA, which consequentially predicted deficits in overnight memory retention and hippocampus-dependent memory transformation. Of the three, the third, sleep-dependent, model provided the superior statistical fit (Fig. 4c). Specifically, this sleep-dependent model provided (i) the lowest RMR (RMR=0.006, compared to 0.021 for Model 1 and 0.021 for Model 2), (ii) the only GFI above 0.9 (GFI=0.931, compared to 0.858 for Model 1 and 0.873 for Model 2), and (iii) the lowest BIC value (BIC=24.676, compared to 29.640 for Model 1 and 29.131 for Model 2). Moreover, only the sleep-dependent model outperformed both the saturation (RMR=0.000, GFI=1.000, BIC: 30.910) and independence control models (RMR=0.046, GFI=0.617, BIC: 30.747). Critically, however, while all three models demonstrated significant associations between (i) NREM SWA 0.6–1Hz and post-sleep retrieval-related hippocampal activation (all P<0.005; Fig. 4a–c), and (ii) post-sleep retrieval-related hippocampal activation and overnight memory retention (all P<0.010; Fig. 4a–c), the only significant path linking mPFC Aβ pathology to impaired memory retention was the sleep-dependent model (Model 3), by way of the influence of mPFC Aβ on NREM SWA (P=0.017; Fig. 4c). These results indicate that the association between mPFC Aβ pathology and diminished memory consolidation is significantly accounted for by the impairing influence of mPFC Aβ pathology on NREM SWA, resulting in a profile of greater overnight forgetting and persistent reliance on the hippocampus during next day retrieval.
Figure 4

Path models linking Aβ, NREM SWA, retrieval-related hippocampus activation, and memory retention

Path analysis models examining the relative contributions of [11C]PIB-PET DVR measured mPFC β-amyloid (Aβ) deposition, proportion of mPFC NREM SWA 0.6–1Hz, and retrieval-related hippocampal (HC) activation to overnight memory retention (long delay recognition testing — short delay recognition testing) in three hypothesized models (a–c). Values represent standardized regression weights. Models were estimated and model fit for the sleep and HC-independent model (a, BIC = 29.640; RMR = 0.021; GFI = 0.858), the sleep-independent and HC-dependent model (b, BIC = 29.131; RMR = 0.021; GFI = 0.873), and the sleep-dependent model (c, BIC = 24.676; RMR = 0.006; GFI = 0.931) were compared against a saturated model (BIC = 30.910; RMR = 0.000; GFI = 1.000), and an independence model (BIC = 30.747; RMR = 0.046; GFI = 0.617). * denotes path significance at P<0.05.

Discussion

To the best of our knowledge, the current findings provide the first evidence that cortical Aβ pathology is associated with impaired generation of NREM slow wave oscillations that, in turn, predict the failure in long-term hippocampus-dependent memory consolidation. While it is important to recognize that the current findings are cross-sectional and correlational, limiting causal claims, they nevertheless establish that the factors of Aβ and NREM sleep physiology and hippocampus-dependent memory are significantly and directionally inter-related. Thus, in addition to already established pathways associated with diminished cognitive function[2, 3, 5, 6], Aβ may additionally impair hippocampus-dependent memory in older adults through its impact on NREM SWA. Moreover, since sleep is a potentially modifiable factor, such findings raise the possibility that therapeutic sleep intervention may aid in minimizing the degree of cognitive decline associated with β-amyloid pathology in old age. To date, age-related NREM sleep disruption has been described in older adult, MCI, and AD cohorts[13, 16–18]. Moreover, subjective reports of poor quality sleep are associated with high Aβ burden in healthy older individuals[21], with reductions in SWS and REM sleep time associated with CSF Aβ and tau protein levels in AD patients[18]. These findings are supported by animal studies linking Aβ pathology to NREM sleep fragmentation[20]. The current study extends these reports by demonstrating that regionally specific aggregation of Aβ within mPFC is associated with the selective electrophysiological impairment of NREM slow wave activity, and that this sleep disruption subsequently correlates with impaired hippocampal-neocortical memory transformation and related overnight memory retention. Our findings further highlight specificity within this pathological interaction at two levels: anatomical and electrophysiological. Anatomically, the selective association between mPFC Aβ pathology (and not other common Aβ accumulating regions) and diminished slow waves suggests that this region may be especially critical to the generation of such NREM sleep oscillations. Indeed, source localization analyses in healthy young adults has revealed slow wave generators within the same mPFC regions that commonly suffer early and extensive Aβ burden[2, 4, 15]. Electrophysiologically, the Aβ association with NREM SWA was additionally specific to the low frequency range of SWA between 0.6–1Hz. This is of particular relevance considering the recognition of the two mechanistically distinct forms of NREM slow waves: the <1Hz slow oscillation and the delta wave (1–4 Hz)[36, 37]. While the mechanisms underlying the mPFC Aβ frequency-specific association identified in the current study (0.6–1Hz) remains unknown, it is plausible that β-amyloid pathology impacts the generation/expression of slow oscillations through an impact on coordinated cortico-thalamic hyperpolarized down states and depolarized up states[36, 37]. This may include the recognized reduction in synaptic NMDAR functioning by Aβ[38, 39]; receptors that are also necessary to generate NREM slow oscillations (and not delta waves)[36-39]. In addition, or alternatively, Aβ may exacerbate age-related prefrontal atrophy due to the neurotoxic effects of Aβ[2, 3, 38, 39] or Aβ-coordinated spread of tau pathology through hippocampal-thalamic loops that interact with the reticular nucleus of the thalamus and the cortico-thalamic loops that generate NREM slow oscillations[3, 5, 40]. Importantly, all these hypotheses offer clear, testable predictions for future exploration within varied clinical and animal model systems. In addition to Aβ being associated with diminished NREM sleep, a growing body of evidence suggests that NREM sleep disruption reciprocally promotes the build-up of Aβ. Interstitial Aβ levels in both humans and rodents rise during periods of wakefulness and fall during sleep[19]. Moreover, sleep deprivation increases Aβ plaque formation in rodent cortex[19] and alters CSF Aβ levels in humans[41], yet the presence of NREM sleep facilitates Aβ clearance[19, 22]. These data, combined with evidence linking Aβ pathology to NREM sleep disruption in rodents[20] and reduced NREM SWA between 0.6–1Hz in the current study, supports the interpretation of a bidirectional relationship between sleep and Aβ pathology. While remaining speculative, such an interpretation supports the proposal of a self-perpetuating cycle in which the initial emergence of Aβ impairs the generation of NREM sleep oscillations, which, in turn, consequently results in wake-dependent increases in Aβ while diminishing the sleep-dependent clearance of Aβ[42]. As a result, Aβ buildup would accelerate, exacerbating the pathological cascade leading to AD[3]. Beyond the association between Aβ burden and impaired NREM SWA, the current findings additionally characterize a functional consequence of this association: impaired overnight consolidation of long-term memory. While prior evidence suggests that the strength of association between Aβ burden and memory retention in healthy older adults is only modest when memory is assessed immediately after encoding[1, 3, 6], the current findings indicate that this association becomes significant when the retention interval is delayed, and thus involves sleep-dependent memory processes. Consequentially, our data suggest that one additional novel pathway linking cortical Aβ pathology to hippocampus-dependent long-term memory functioning is through the association between Aβ aggregation and disrupted NREM slow oscillations. Specifically, the data support a model in which the severity of Aβ aggregation in mPFC regions that generate NREM slow waves[15] predicts reductions in NREM slow waves 0.6–1Hz. This reduction, in turn, is associated with diminished sleep-dependent memory consolidation and the persistence (rather than the typical progressive independence[27, 28, 11, 30]) of next day memory retrieval upon hippocampal activity. Indeed, results from the path analyses support the hypothesis that the influence of mPFC Aβ on hippocampus-dependent memory consolidation was not direct, but through its impact on NREM slow waves 0.6–1Hz. These associations remained robust when adjusting for age, gender, and atrophy. Importantly, it should be noted that these data in no way preclude the possibility that Aβ can influence memory independent of NREM slow waves, or that other factors, such as atrophy or tau pathology may influence memory independent of or dependent on associations with NREM slow waves. While the SEM models did demonstrate significant inter-relatedness between Aβ pathology, NREM sleep, and hippocampus-dependent memory, it does not explain the influence of other, unmeasured factors, such as tau pathology, which may explain additional variance in age-related, sleep-dependent memory impairment. It is therefore necessary for future studies to employ models that examine multiple factors associated with age-related cognitive decline, to develop a more comprehensive account of how these factors interact with sleep and impact sleep-dependent memory. However, these findings do establish that one influence of Aβ pathology on hippocampus-dependent memory includes an impact on the cortical generation of NREM slow waves and the associated consolidation of sleep-dependent memory. Building on this model, and more generally, our findings offer several clinical and public health considerations. First, should these associations prove to be causal in cognitively normal older adults and AD cohorts, screening for and treating NREM slow wave sleep abnormalities in older adult populations may aid in reducing both the risk for developing AD and the rate at which AD progresses. Indeed, disordered sleep is recognized to carry an increased risk for cognitive decline and AD[43, 44], while superior sleep quality is associated with resilience to cognitive decline and a reduced risk of developing AD[45]. Second, since associations between Aβ pathology and NREM sleep physiology are observed in preclinical older adults as well as in MCI and AD cohorts[13, 18], it is possible that sleep disruption, specifically in the electrophysiological index of NREM slow oscillatory activity (<1Hz), may represent an additional preclinical AD biomarker. Finally, these data offer the empirical foundations on which future work may determine whether Aβ-related sleep disruption plays a causal role in the progression of cognitive decline in neurodegenerative dementias. They further warrant the exploration of whether interventions that promote NREM SWA (in the 0.6–1Hz frequency range) minimize the progression of neurodegeneration and the cognitive dysfunction associated with Aβ pathology.

Methods

Thirty healthy older adult participants were recruited, with twenty-six participants completing the study (18 females, mean±s.d., 75.1±3.5 years; Table 1). No statistical methods were used to pre-determine sample sizes, but our sample sizes are similar to those reported in previous publications[6–8, 11, 47]. Data from ten of these participants were included in a previous publication[11]. These ten participants were selected for the present study, as they were the only participants with concurrently acquired PIB-PET data. The study was approved by the local human studies committee, with all participants providing written informed consent. Exclusion criteria included presence of neurologic, psychiatric or sleep disorders, current use of antidepressant or hypnotic medications, or being left handed. Participants were free of depressive symptoms[48], and all scored >25 on the mini mental state exam[49]. Further, and in addition to neuroradiological assessments and medical interviews (cf.[11, 47]; obtained within one year of study entry), participants performed within 1.5 standard deviations of their age, gender, and education-matched control group on tests of 1) episodic memory[50, 51] and 2) frontal function[52, 53] (Table 1). Episodic memory task data were specifically excluded when below two standard deviations of the mean across participants, or when performing at chance levels. PIB DVR does not follow a normal distribution, and, unlike behavioral assessment, there are no numerical boundaries of the PIB DVR measure that render this metric without scientific or clinical relevance. Consequently, there was no PIB DVR exclusion threshold (within biological limits) employed in the current study. Prior to study entry, participants underwent sleep disorders screening with a polysomnography (PSG) recording night (described below) reviewed by a board certified sleep medicine specialist (author B.L.). Participants were excluded if they displayed evidence of a parasomnia or an Apnea/Hypopnea Index ≥15[54], with four participants being excluded due to evidence of sleep apnea). All participants abstained from caffeine, alcohol, and daytime naps for the 48 hr before and during the study. Participants kept normal, habitual sleep-wake rhythms and averaged 7–9 hr of reported time in bed per night prior to study participation, verified by sleep logs (Table 1). The recording of sleep in the laboratory environment, as in the current study, is advantageous for a number of data acquisition and quality control reasons. However, it represents an important limitation considering that sleep amounts and efficiency are often greater in the home setting. While total sleep time and NREM SWS time often differ across these two contexts, it is of note that the measure of NREM sleep spectral EEG power is highly consistent across nights within an individual in a variety of contexts, such that within-subject night-to-night variability is much smaller than between subjects variability in NREM SWA[55, 56]. This is of potential relevance to the current findings, since it was spectral NREM SWA that demonstrated associations with PIB and memory measures rather than any sleep stage metrics. Nevertheless, home PSG assessments will be necessary to provide a more ecologically valid exploration of the interaction between β-amyloid pathology, sleep and memory.

General Experimental Design

All participants underwent positron emission tomography (PET) scanning following [11C]PIB injection. Within one year of PIB-PET scanning, participants then entered the lab in the evening and trained to criterion on a sleep-dependent episodic memory task (describe below), followed by a short delay (10 min) recognition test. Participants were then given an 8 hour sleep opportunity, measured with PSG, starting at their habitual bed time (Table 1). Approximately two hours post-awakening, participants performed an event-related functional MRI (fMRI) scanning session while performing a long delay (10 hr) recognition test. PIB-PET data were acquired and analyzed separately (authors S.M. and J.V.) from all other data analyzed (author B.M.), thus ensuring PSG, fMRI, and memory data acquisition, preprocessing, and analysis were conducted blind to participant Aβ status.

Episodic Memory Task

The word-pairs task[11] had an intentional encoding phase immediately followed by a training to criterion phase, which was then followed by a short delay recognition test (10 min; 30 studied trials and 15 foil trials) and a long delay recognition test (10 hr, occurring 2 hours post-awakening within the MRI scanner; 90 studied trials and 45 foil trials). As described previously[11], associative recognition memory was calculated by subtracting both the ‘False alarm rate’ (FAR; proportion of foil words endorsed as “previously studied”) and the ‘Lure rate’ (LR; proportion of previously studied words erroneously paired with the lure) from the ‘Hit rate’ (HR; proportion of previously studied words paired with the correct nonsense word).[11] Episodic memory retention was subsequently calculated as the difference in short and long delay recognition memory performance [long delay – short delay][11, 57]. Two participants were excluded from analysis as outliers (memory performance more than 2 standard deviations from the mean), and two participants had memory and fMRI data lost due to computer theft.

PET scanning and analysis

PIB-PET scans were collected within one year of sleep and memory assessment, as PIB distribution volume ratio (DVR) values change minimally within this duration[58, 59]. Scanning was performed on 23 participants using a Siemens ECAT EXACT HR PET scanner and on 3 participants using a Siemens Biograph 6 PET/CT scanner in 3D acquisition mode post [11C]PIB injection (approximately 15 mCi) into the antecubital vein. PIB DVR values have been shown to be highly comparable across these two scanners, having no effect on the global PIB measure[60]. Dynamic acquisition frames were obtained over 90 minutes, as reported[6, 61], following transmission or CT scans for attenuation correction. PIB-PET data were reconstructed using an ordered subset expectation maximization algorithm with weighted attenuation, and images were smoothed using a 4 mm Gaussian kernel with scatter correction. Each image is evaluated for excessive motion and adequacy of statistical counts. PET image processing and analysis were performed using SPM8 to realign frames. Realigned PIB frames from the first 20 minutes of acquisition were averaged and used to guide coregistration of each individual’s PIB-PET scan to their structural MRI scan. Logan graphical analysis was used to calculate voxel-wise distribution volume ratios (DVRs) with a cerebellar grey matter region of interest (ROI) used as a reference region, as described previously[6, 61]. This analysis yielded a voxelwise DVR image for each participant. Targeting our mPFC hypothesis, the following Desikan-Killiany Atlas-derived[62] regions were used to construct our mPFC ROI: left and right hemisphere superior frontal, rostral and caudal anterior cingulate, and medial orbitofrontal regions (Fig. 1a). In addition, occipital cortex (right and left hemisphere cuneus, lingual, pericalcarine, and lateral occipital regions), temporal cortex (right and left hemisphere middle and superior temporal regions), parietal cortex (right and left hemisphere inferior and superior parietal, supramarginal gyrus, and precuneus regions), and dorsolateral prefrontal cortex (right and left hemisphere rostral and caudal middle frontal, pars opercularis, and pars triangularis regions; DLPFC) ROIs were used as control measures to determine specificity of mPFC Aβ effects. ROI DVR values were derived by calculating the mean of all voxelwise DVR values within each ROI. To account for the non-normal distribution of Aβ in the population, DVR measures were normalized using the natural logarithm, as described previously[63-65].

MRI scanning

Scanning was performed on a Siemens Trio 3 Tesla scanner equipped with a 32-channel head coil. Functional scans were acquired using a susceptibility-weighted, single-shot echo-planar imaging (EPI) method to image the regional distribution of the blood oxygenation level-dependent signal [time repetition (TR)/time echo (TE) 2000/23 ms; flip angle 90°; FatSat, FOV 224 mm; matrix 64×64; 37 3mm slices with 0.3mm slice gap, descending sequential acquisition], and using parallel imaging reconstruction (GRAPPA) with acceleration factor 2. Three functional runs were acquired (159 volumes, 5.3 minutes). Following functional scanning, two high-resolution T1-weighted anatomical images were acquired using a 3D MPRAGE protocol with the following parameters: repetition time (TR), 1900 ms; echo time (TE), 2.52 ms; flip angle, 9°; field of view (FOV), 256 mm; matrix, 256 × 256; slice thickness, 1.0 mm; and 176 slices. Optimized voxel-based morphometry (VBM) was performed on coregistered mean MPRAGE images to examine grey matter volume within the same mPFC ROI used to extract mPFC PIB DVR values; VBM methods described in detail in[11].

fMRI analysis

Functional MRI data were analyzed using SPM8 (Wellcome Department of Imaging Neuroscience; http://www.fil.ion.ucl.ac.uk/spm/software/) beginning with standardized preprocessing (realignment, slice timing correction, and coregistration), and with normalization accomplished using a template containing elderly brains, as described previously[11, 47]. Following preprocessing, retrieval trials were sorted into “Hits” (correct word-nonsense word recognition), “Lures” (selection of the incorrect, previously studied, nonsense word), “Misses” (incorrect selection of never studied nonsense word or endorsement of word as “new”), “Correct Rejections” (novel words correctly endorsed as “new”), “False Alarms” (novel words incorrectly endorsed as “studied”), and “Omissions” (trials with no subject response)[11], with each trial modeled using a canonical hemodynamic response function. To generate a validated contrast for retrieval-related activity, Hit events were contrasted with Correct Rejection events [Hits – Correct Rejections][11]. Individual activation maps were then taken to a second-level random effects analysis to examine retrieval-related activation negatively associated with NREM SWA and overnight memory retention measures. Activations were assessed at the voxel level of p<0.05 family wise error (FWE)[66] corrected for multiple comparisons within an a priori hippocampal region of interest (ROI; 8 mm sphere [x=−22, y=−14, z=−12][24] in Talairach space and [x=−23, y=−15, z=−16] after MNI conversion[67]), further inclusively masked using an anatomical hippocampus ROI. To determine associations between hippocampus activation and other variables of interest, the cluster average of significant voxels was extracted using Marsbar[46].

Sleep monitoring and EEG analysis

PSG on the experimental night was recorded using a Grass Technologies Comet XL system (Astro-Med, inc., West Warwick, RI), including 19-channel electroencephalography (EEG) placed using the 10–20 system, electrooculography (EOG) recorded at the right and left outer canthi (right superior; left inferior), and electromyography (EMG). Reference electrodes were recorded at both the left and right mastoid (A1, A2). Data were digitized at 400Hz, and stored unfiltered (recovered frequency range of 0.1–100 Hz), except for a 60-Hz notch filter. Sleep was scored using standard criteria[68]. Sleep monitoring on the screening night was recorded using a Grass Technologies AURA PSG Ambulatory system (Astro-Med, inc., West Warwick, RI), and additionally included nasal/oral airflow, abdominal and chest belts, and pulse oximetry. EEG data from the experimental night were imported into EEGLAB (http://sccn.ucsd.edu/eeglab/) and epoched into 5 s bins. Epochs containing artifacts were manually rejected by a trained scorer (author B.A.M.), and the remaining epochs were filtered between 0.4–50Hz (645±80 epochs per participant with 4.6%±2.1% of epochs rejected). A fast Fourier transform (FFT) was then applied to the filtered EEG signal at 5-second intervals with 50% overlap and employing hanning windowing. Analyses in the current report focused, a priori, on slow wave activity (SWA), defined as relative spectral power between 0.6–4.6Hz during slow wave sleep (NREM stages 3&4)[10, 11]. Spectral power was subdivided into two bins for analysis (0.6–1Hz/1–4Hz), to examine the impact of β-amyloid on SWA frequencies particularly relevant to memory functions[14, 23]. A single summary proportional measure was also derived by dividing the spectral power between 0.6–1Hz by the sum of spectral power between 0.6–4Hz, to determine the relative dominance of memory-relevant slow waves. Furthermore, due to our a priori focus on mPFC, SWA measures at FZ and CZ derivations were averaged and used as a measure of mPFC SWA (Fig. 1b). To ascertain topographic specificity of effects, SWA measures at F3, F4, F7, and F8 derivations were averaged and used as a measure of dlPFC SWA, SWA measures at P3, P4, and PZ derivations were averaged and used as a measure of Parietal SWA, SWA measures at T3, T4, T5, and T6 derivations were averaged and used as a measure of Temporal SWA, and SWA measures at O1 and O2 derivations were averaged and used as a measure of Occipital SWA. Slow wave detection and source analysis were performed to (1) calculate the impact of mPFC Aβ on slow wave density, and (2) determine whether memory-relevant FZ and CZ measured slow waves (0.6–1Hz) have an mPFC source (Fig. 1b and Supplementary Fig. 1). EEG data were filtered between 0.5–4Hz, and individual slow waves were detected using a validated algorithm[25]. Standardized low resolution brain electromagnetic tomography (sLORETA) was employed[26] as previously described[69, 70]. In short, this method calculates current density sources using a discrete, three-dimensionally distributed, linear minimum norm solution to the forward problem. Computations are made using a head model based on the MNI152 template[71]. Prior to sLORETA analysis, EEG preprocessing was conducted in MATLAB using the EEGLAB toolbox. For each participant, filtered (0.5Hz–4Hz), artifact-rejected EEG was event-marked separately for detected slow wave (0.6–1Hz) midpoints in the FZ and CZ derivations. EEG was then epoched around each detected slow wave midpoint (±100 ms). Slow wave epochs were then averaged and exported separately for CZ and FZ detected slow waves. sLORETA analyses of slow wave epochs were carried out using the freeware sLORETA utilities (http://www.uzh.ch/keyinst/loreta.htm), consistent with previous source analysis examinations[69, 70]. Prior to current density source calculation, all electrode derivations were registered and transformed into 3D MNI space, yielding a spatial transformation matrix. Current density source maps were then derived for each participant separately for CZ and FZ time-locked EEG averages. CZ and FZ source maps were then averaged within each participant, with CZ-FZ averaged source maps then averaged across participants to generate a grand mean average source image for memory-relevant CZ and FZ slow waves (Supplementary Fig. 1).

Statistical Analysis

Two-way repeated measures ANCOVA models were used to determine the influence of PIB-PET measures on NREM slow wave measures, with PIB-PET DVR measures as a between subjects covariate and frequency (0.6–1Hz/1–4hz) as a within-subjects factor. Associations between PIB DVR measures, sleep measures, hippocampal activation, and episodic memory retention were assessed using regression models. Normality was formally tested, and all variables exhibited the skewness and kurtosis of a normal distribution except PIB-PET DVR measures, which exhibited a normal kurtosis but a right skewed distribution. Since PIB-PET DVR measures followed a right skewed non-normal distribution, PIB DVR values were natural logarithm transformed before analysis and regressions were further affirmed with follow-up nonparametric Kendall’s Tau correlations. Analyses were completed using SPSS version 22.0 (SPSS, Inc., Chicago, IL). To determine whether mPFC Aβ statistically influenced hippocampal-dependent episodic memory retention through mPFC NREM SWA, path analyses were performed using a structural equation modeling framework[32, 34] in Amos version 22 (IBM Corp., Armonk, NY). This multivariate modeling technique calculates the path coefficients, i.e. coupling between model variables, given a specified model. Path coefficients reflect the direct and proportional influence of one variable on another while controlling for other variables in the model. Three hypothesized models were specified with an equal number of paths. These models were then compared to each other and saturation and independence models. The first model allowed Aβ to directly impact memory retention independently of NREM SWA. The second model allowed Aβ to impact memory retention independently of NREM SWA, but this time indirectly through its effects on hippocampal activation. Finally, model three instead required Aβ to impact memory retention solely through its influence on NREM SWA. Three validated metrics were used to compare model fits: BIC (Bayesian information criterion), RMR (root mean square residual), and GFI (goodness of fit index)[33-35]. In short, models with RMR near 0 and GFI above 0.9 were considered sufficient model fits[34]. The model with the lowest BIC value was considered the superior model, with a difference of 10+ suggesting large model differences, a difference of 6–10 suggesting medium model differences, and a difference of 2–6 suggesting small model differences are present[35]. Within the superior model, individual path coefficients were then examined for significance. A supplementary methods checklist is available.
  61 in total

1.  Polysomnographic and subjective sleep markers of mild cognitive impairment.

Authors:  Eva Hita-Yañez; Mercedes Atienza; Jose L Cantero
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

2.  Frontotemporal network connectivity during memory encoding is increased with aging and disrupted by beta-amyloid.

Authors:  Hwamee Oh; William J Jagust
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

3.  Much of late life cognitive decline is not due to common neurodegenerative pathologies.

Authors:  Patricia A Boyle; Robert S Wilson; Lei Yu; Alasdair M Barr; William G Honer; Julie A Schneider; David A Bennett
Journal:  Ann Neurol       Date:  2013-07-10       Impact factor: 10.422

4.  Brain β-amyloid load approaches a plateau.

Authors:  Clifford R Jack; Heather J Wiste; Timothy G Lesnick; Stephen D Weigand; David S Knopman; Prashanthi Vemuri; Vernon S Pankratz; Matthew L Senjem; Jeffrey L Gunter; Michelle M Mielke; Val J Lowe; Bradley F Boeve; Ronald C Petersen
Journal:  Neurology       Date:  2013-02-27       Impact factor: 9.910

5.  CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology.

Authors:  Elizabeth M Bradshaw; Lori B Chibnik; Brendan T Keenan; Linda Ottoboni; Towfique Raj; Anna Tang; Laura L Rosenkrantz; Selina Imboywa; Michelle Lee; Alina Von Korff; Martha C Morris; Denis A Evans; Keith Johnson; Reisa A Sperling; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Nat Neurosci       Date:  2013-05-23       Impact factor: 24.884

6.  Structural brain correlates of human sleep oscillations.

Authors:  Jared M Saletin; Els van der Helm; Matthew P Walker
Journal:  Neuroimage       Date:  2013-06-14       Impact factor: 6.556

7.  Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.

Authors:  Andrew S P Lim; Lei Yu; Matthew Kowgier; Julie A Schneider; Aron S Buchman; David A Bennett
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

8.  Self-reported sleep and β-amyloid deposition in community-dwelling older adults.

Authors:  Adam P Spira; Alyssa A Gamaldo; Yang An; Mark N Wu; Eleanor M Simonsick; Murat Bilgel; Yun Zhou; Dean F Wong; Luigi Ferrucci; Susan M Resnick
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

9.  Sleep drives metabolite clearance from the adult brain.

Authors:  Lulu Xie; Hongyi Kang; Qiwu Xu; Michael J Chen; Yonghong Liao; Meenakshisundaram Thiyagarajan; John O'Donnell; Daniel J Christensen; Charles Nicholson; Jeffrey J Iliff; Takahiro Takano; Rashid Deane; Maiken Nedergaard
Journal:  Science       Date:  2013-10-18       Impact factor: 47.728

10.  Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging.

Authors:  Bryce A Mander; Vikram Rao; Brandon Lu; Jared M Saletin; John R Lindquist; Sonia Ancoli-Israel; William Jagust; Matthew P Walker
Journal:  Nat Neurosci       Date:  2013-01-27       Impact factor: 24.884

View more
  144 in total

1.  Genetic Correlation Analysis Suggests Association between Increased Self-Reported Sleep Duration in Adults and Schizophrenia and Type 2 Diabetes.

Authors:  Enda M Byrne; Philip R Gehrman; Maciej Trzaskowski; Henning Tiemeier; Allan I Pack
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

2.  Sleep: Amyloid-β accumulation impairs memory by disrupting deep sleep--but could the vicious cycle be stopped?

Authors:  Hemi Malkki
Journal:  Nat Rev Neurol       Date:  2015-06-09       Impact factor: 42.937

Review 3.  Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning.

Authors:  György Buzsáki
Journal:  Hippocampus       Date:  2015-10       Impact factor: 3.899

Review 4.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

5.  BACE inhibition-dependent repair of Alzheimer's pathophysiology.

Authors:  Aylin D Keskin; Maja Kekuš; Helmuth Adelsberger; Ulf Neumann; Derya R Shimshek; Beomjong Song; Benedikt Zott; Tingying Peng; Hans Förstl; Matthias Staufenbiel; Israel Nelken; Bert Sakmann; Arthur Konnerth; Marc Aurel Busche
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 6.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 7.  It's complicated: The relationship between sleep and Alzheimer's disease in humans.

Authors:  Brendan P Lucey
Journal:  Neurobiol Dis       Date:  2020-07-29       Impact factor: 5.996

Review 8.  Sleep as a Therapeutic Target in the Aging Brain.

Authors:  Thierno M Bah; James Goodman; Jeffrey J Iliff
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 9.  Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology.

Authors:  Anna E Mullins; Korey Kam; Ankit Parekh; Omonigho M Bubu; Ricardo S Osorio; Andrew W Varga
Journal:  Neurobiol Dis       Date:  2020-08-27       Impact factor: 5.996

10.  Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.

Authors:  Andrew W Varga; Margaret E Wohlleber; Sandra Giménez; Sergio Romero; Joan F Alonso; Emma L Ducca; Korey Kam; Clifton Lewis; Emily B Tanzi; Samuel Tweardy; Akifumi Kishi; Ankit Parekh; Esther Fischer; Tyler Gumb; Daniel Alcolea; Juan Fortea; Alberto Lleó; Kaj Blennow; Henrik Zetterberg; Lisa Mosconi; Lidia Glodzik; Elizabeth Pirraglia; Omar E Burschtin; Mony J de Leon; David M Rapoport; Shou-En Lu; Indu Ayappa; Ricardo S Osorio
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.